A prognostic test to guide adjuvant chemotherapy (ACT) decisions in early-stage non-small cell lung cancer (NSCLC): A cost-effectiveness analysis.

被引：0
|
作者：
Stenehjem, David D.
Bellows, Brandon Kyle
Kaldate, Rajesh R.
Jones, Joshua Timothy
Siebert, Uwe
Brixner, Diana I.
机构：
[1] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[2] Univ Utah, Pharmacotherapy Outcomes Res Ctr, Salt Lake City, UT USA
[3] Myriad Genet Labs Inc, Salt Lake City, UT USA
[4] Myriad Genet Inc, Salt Lake City, UT USA
[5] Univ Hlth Sci Med Informat & Technol, Hall In Tirol, Austria
[6] Univ Utah, LS Skaggs Pharm Inst, Salt Lake City, UT USA
[7] Univ Utah, Program Personalized Hlth Care, Salt Lake City, UT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e18509
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18509
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Changes in chemotherapy uptake and wait times in early-stage non-small cell lung cancer (NSCLC)
    Gray, S. L.
    Bu, J.
    Saint-Jacques, N.
    Rayson, D.
    Younis, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] COST-EFFECTIVENESS OF DURVALUMAB AFTER CHEMORADIATION IN STAGE III NON-SMALL CELL LUNG CANCER (NSCLC)
    Criss, S. D.
    Mooradian, M. J.
    Lumish, M. A.
    Reynolds, K. L.
    Kong, C. Y.
    VALUE IN HEALTH, 2018, 21 : S12 - S12
  • [23] Waiting times in early-stage non-small cell lung cancer (NSCLC)
    Saint-Jacques, Nathalie
    Rayson, Daniel
    Al-Fayea, Turki
    Virik, Kiran
    Morzycki, Wojciech
    Younis, Tallal
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (08) : 865 - 870
  • [24] Proton therapy for early-stage non-small cell lung cancer (NSCLC)
    Gomez, Daniel R.
    Li, Heng
    Chang, Joe Y.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (02) : 199 - 204
  • [25] Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer
    Shukla, Nikhil
    Hanna, Nasser
    LUNG CANCER-TARGETS AND THERAPY, 2021, 12 : 51 - 60
  • [26] COST-EFFECTIVENESS OF THE PERVENIO™ RISK-SCORE (RS) ASSAY IN EARLY-STAGE NON-SMALL CELL LUNG CANCER
    Roth, Joshua A.
    Billings, Paul
    Ramsey, Scott D.
    Dumanois, Robert
    Carlson, Josh J.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S499 - S499
  • [27] Adjuvant Chemotherapy Following SBRT for Early Stage Non-Small Cell Lung Cancer (NSCLC) in Older Patients
    Ganti, A. K.
    Appiah, A. Kusi
    Ernani, V.
    Zhang, C.
    Zhen, W.
    Marr, A.
    Smith, L.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S255 - S255
  • [28] Adjuvant chemotherapy following SBRT for early stage non-small cell lung cancer (NSCLC) in older patients
    Grinnell, Madison
    Appiah, Adams Kusi
    Baine, Michael
    Ernani, Vinicius
    Marr, Alissa
    Zhang, Chi
    Zhen, Weining
    Buddharaju, Laxmi Narayana R.
    Smith, Lynette M.
    Ganti, Apar Kishor
    JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (07) : 1145 - 1153
  • [29] COST-EFFECTIVENESS ANALYSIS OF STEREOTACTIC BODY RADIOTHERAPY AND RADIOFREQUENCY ABLATION FOR MEDICALLY INOPERABLE, EARLY-STAGE NON-SMALL CELL LUNG CANCER
    Sher, David J.
    Wee, Jon O.
    Punglia, Rinaa S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : E767 - E774
  • [30] Comparing the costs and cost-effectiveness of new chemotherapy regimens for treating non-small cell lung cancer (NSCLC).
    Gralla, RJ
    Grusenmeyer, PA
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : PP26 - PP26
12345